Iceland· IS-EU/1/17/1188/003
Spinraza
A nusinersen product containing nusinersenum inn, registered in Iceland by Biogen Netherlands B.V.. The same ATC class is registered in 13 of our 19 countries.
Checked against Icelandic Medicines Agency (Iceland) on
Informational only — not a medical device.
Where it is registered
Nusinersen is registered in 13 of 19 countries.
Countries holding a registration under ATC M09AX07 (nusinersen), each read from that country’s own register.
- This record: Iceland, from Icelandic Medicines Agency (Iceland)
- 8 of them publish a price we can compare per daily dose
Nusinersen · ATC M09AX07
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of nusinersen costs, country by country.
Normalised to the WHO defined daily dose (0.1 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Nusinersen · price per daily dose (0.1 mg)
USD · FX 28 Sept 2026
- CH Switzerland$531.69
The record
At a glance
Icelandic Medicines Agency (Iceland)- Active substance
- Nusinersenum INN
- Manufacturer
- Biogen Netherlands B.V.
- Country
- Iceland (IS)
- ATC code
- M09AX07
- ATC class
- Nusinersen
- Defined daily dose
- 0.1 mg, P
- Reimbursed
- Not published by this register
- Source register
- Icelandic Medicines Agency (Iceland)
- Last checked
- September 29, 2026
Packs & prices · 1
1 priced- ean4718985 ml x1 hglISK 25919777
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Nusinersen in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainSPINRAZA 50 MG SOLUCION INYECTABLEBiogen Netherlands B.V.
- FinlandSpinrazaBiogen Netherlands B.V.
- NetherlandsSpinraza 50 mg oplossing voor injectieBiogen Netherlands B.V.
- PolandSpinrazaBiogen Netherlands B.V.
- SwedenSpinraza 50 mg Injektionsvätska, lösningBiogen Netherlands B.V.
- SwitzerlandSpinraza 12mg/5ml, Injektionslösung zur intrathekalen InjektionBiogen Switzerland AG
- United StatesSpinrazaBiogen Inc.
- IrelandSpinraza 12 mg solution for injectionBiogen Netherlands B.V.
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Liechtenstein · Spinraza
- Norway · Spinraza
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/88031d91-a8b7-4b7e-a640-f9447ac02887 GET /v1/drugs/88031d91-a8b7-4b7e-a640-f9447ac02887?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Stungulyf, lausn",
"source": "lyfjastofnun",
"atc_raw": "M09AX07",
"marketed": true,
"strength": "50 mg",
"ma_number": "EU/1/17/1188/003",
"substance": "Nusinersenum INN",
"other_info": null,
"legal_status": "(R) Lyfseðilsskylt\r\n(H) Sjúkrahúsmerkt",
"ma_issued_serial": "46031"
}See everything about nusinersen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.